2018
DOI: 10.21037/jtd.2018.01.132
|View full text |Cite
|
Sign up to set email alerts
|

Lung surgery in elderly patients: are we doing enough?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
3
1

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 12 publications
0
3
0
1
Order By: Relevance
“…Commonly, the most used cutoff to define elderly patients is an age of 70 and above (3). There is evidence that older patients are at risk for substandard treatment when compared to the younger counterparts due to a reluctance to choose surgical approach because of the concerns regarding pre-existing comorbidities, outcomes and limited life expectancy (4).…”
Section: Introductionmentioning
confidence: 99%
“…Commonly, the most used cutoff to define elderly patients is an age of 70 and above (3). There is evidence that older patients are at risk for substandard treatment when compared to the younger counterparts due to a reluctance to choose surgical approach because of the concerns regarding pre-existing comorbidities, outcomes and limited life expectancy (4).…”
Section: Introductionmentioning
confidence: 99%
“…The need for lung cancer care for older adults is expected to increase, in part due to population-wide screening in high-risk patients 1,2 . While surgery represents the mainstay of curative-intent treatment for stage I non–small cell lung cancer (NSCLC), 3 lung resection can be associated with a higher risk in older adults, owing to the higher prevalence of frailty in this population 4 …”
mentioning
confidence: 99%
“…1,2 While surgery represents the mainstay of curative-intent treatment for stage I non-small cell lung cancer (NSCLC), 3 lung resection can be associated with a higher risk in older adults, owing to the higher prevalence of frailty in this population. 4 The best evidence for less invasive treatments is currently for stereotactic body radiation therapy (SBRT), which provides an opportunity for good local control with a low toxicity profile. 5,6 Retrospective cohort studies have reported the safety and feasibility of SBRT for treating patients with early-stage lung cancer.…”
mentioning
confidence: 99%
“…Οι χειρουργικές τεχνικές εφαρμόζονται πλέον στους ηλικιωμένους με καλά αποτελέσματα χάρη στη βελτιωμένη τεχνογνωσία και τη χειρουργική εμπειρία. Ωστόσο, το ποσοστό μετεγχειρητικής θνησιμότητας στους μεγαλύτερους ασθενείς είναι υψηλότερο σε σχέση με εκείνο των νεώτερων ατόμων (Scarci et al, 2018).…”
Section: καρκίνος του πνεύμονα στους ηλικιωμένουςunclassified